bpc-157 fda compounding category Peptide Review 2026: What This Big Shift Means HIMS jumps more than 7%

HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA Peptide Update: Category 2 Removals Explained Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157 vs TB 500: Research Compared Dosage Peptide Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law

SKU: 9948999733 · From vesmirnicky.sk